Johnson & Johnson Inventory
Johnson & Johnson (JNJ) had Inventory of $15.14 billion as of 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2026-07-23
- 2026-06-28: Inventory, Net $15.14B.
- 2026-03-29: Inventory, Net $14.58B.
- 2025-12-28: Inventory, Net $14.19B.
- 2025-09-28: Inventory, Net $14.15B.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2026-06-28 | $15.14B 10-Q · filed 2026-07-23 | |
| 2026-03-29 | $14.58B 10-Q · filed 2026-04-22 | |
| 2025-12-28 | $14.19B 10-Q · filed 2026-07-23 | |
| 2025-09-28 | $14.15B 10-Q · filed 2025-10-22 | |
| 2025-06-29 | $13.41B 10-Q · filed 2025-07-24 | |
| 2025-03-30 | $12.66B 10-Q · filed 2025-04-23 | |
| 2024-12-29 | $12.44B 10-K · filed 2026-02-11 | |
| 2024-09-29 | $12.60B 10-Q · filed 2024-10-23 | |
| 2024-06-30 | $12.17B 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $11.38B 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $11.18B 10-K · filed 2025-02-13 | |
| 2023-10-01 | $11.20B 10-Q · filed 2023-10-27 | |
| 2023-07-02 | $12.89B 10-Q · filed 2023-07-31 | |
| 2023-04-02 | $12.81B 10-Q · filed 2023-04-28 | |
| 2023-01-01 | $10.27B 10-K · filed 2024-02-16 | $12.48B 10-K · filed 2023-02-16 |
| 2022-10-02 | $11.68B 10-Q · filed 2022-10-27 | |
| 2022-07-03 | $11.44B 10-Q · filed 2022-07-29 | |
| 2022-04-03 | $10.99B 10-Q · filed 2022-04-29 | |
| 2022-01-02 | $10.39B 10-K · filed 2023-02-16 | |
| 2021-10-03 | $10.39B 10-Q · filed 2021-10-29 | |
| 2021-07-04 | $10.10B 10-Q · filed 2021-07-29 | |
| 2021-04-04 | $9.95B 10-Q · filed 2021-04-30 | |
| 2021-01-03 | $9.34B 10-K · filed 2022-02-17 | |
| 2020-09-27 | $9.60B 10-Q · filed 2020-10-23 | |
| 2020-06-28 | $9.42B 10-Q · filed 2020-07-24 | |
| 2020-03-29 | $8.87B 10-Q · filed 2020-04-29 | |
| 2019-12-29 | $9.02B 10-K · filed 2021-02-22 | |
| 2019-09-29 | $9.17B 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $9.26B 10-Q · filed 2019-07-29 | |
| 2019-03-31 | $9.09B 10-Q · filed 2019-05-01 | |
| 2018-12-30 | $8.60B 10-K · filed 2020-02-18 | |
| 2018-09-30 | $8.68B 10-Q · filed 2018-10-31 | |
| 2018-07-01 | $8.81B 10-Q · filed 2018-08-02 | |
| 2018-04-01 | $9.01B 10-Q · filed 2018-05-01 | |
| 2017-12-31 | $8.77B 10-K · filed 2019-02-20 | |
| 2017-10-01 | $9.52B 10-Q · filed 2017-11-02 | |
| 2017-07-02 | $9.70B 10-Q · filed 2017-08-03 | |
| 2017-04-02 | $8.88B 10-Q · filed 2017-05-08 | |
| 2017-01-01 | $8.14B 10-K · filed 2018-02-21 | |
| 2016-10-02 | $8.49B 10-Q · filed 2016-11-04 | |
| 2016-07-03 | $8.52B 10-Q · filed 2016-08-04 | |
| 2016-04-03 | $8.17B 10-Q · filed 2016-05-10 | |
| 2016-01-03 | $8.05B 10-K · filed 2017-02-27 | |
| 2015-09-27 | $8.21B 10-Q · filed 2015-10-30 | |
| 2015-06-28 | $8.30B 10-Q · filed 2015-07-31 | |
| 2015-03-29 | $8.09B 10-Q · filed 2015-05-01 | |
| 2014-12-28 | $8.18B 10-K · filed 2016-02-24 | |
| 2014-09-28 | $8.42B 10-Q · filed 2014-10-30 | |
| 2014-06-29 | $8.15B 10-Q · filed 2014-08-01 | |
| 2014-03-30 | $8.01B 10-Q · filed 2014-05-02 | |
| 2013-12-29 | $7.88B 10-K · filed 2015-02-24 | |
| 2013-09-29 | $8.12B 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $7.82B 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $7.69B 10-Q · filed 2013-05-03 | |
| 2012-12-30 | $7.50B 10-K · filed 2014-02-21 | |
| 2012-09-30 | $7.81B 10-Q · filed 2012-11-09 | |
| 2012-07-01 | $7.70B 10-Q · filed 2012-08-02 | |
| 2012-04-01 | $6.80B 10-Q · filed 2012-05-07 | |
| 2012-01-01 | $6.29B 10-K · filed 2013-02-22 | |
| 2011-10-02 | $6.43B 10-Q · filed 2011-11-08 | |
| 2011-07-03 | $6.41B 10-Q · filed 2011-08-09 | |
| 2011-04-03 | $6.20B 10-Q · filed 2011-05-10 | |
| 2011-01-02 | $5.38B 10-K · filed 2012-02-23 | |
| 2010-10-03 | $5.41B 10-Q · filed 2010-11-10 | |
| 2010-07-04 | $5.07B 10-Q · filed 2010-08-11 | |
| 2010-04-04 | $5.31B 10-Q · filed 2010-05-10 | |
| 2010-01-03 | $5.18B 10-K · filed 2011-02-25 | |
| 2009-09-27 | $5.57B 10-Q · filed 2009-11-04 | |
| 2009-06-28 | $5.47B 10-Q · filed 2009-08-04 | |
| 2008-12-28 | $5.05B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |